D Hoelzer

High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia.

U. Maurer, C. Miething, L. Bergmann, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

R. Pieters, R. Pieters, H. Dombret, 2010, Leukemia.

Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease.

G Hör, G. Hör, R. Baum, 1999, Leukemia & lymphoma.

High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.

U. Maurer, C. Miething, J. Brieger, 1997, Blood.

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

J M Rowe, H. Dombret, H. Kantarjian, 2016, Blood Cancer Journal.

Histone Acetylation Modifiers in the Pathogenesis of Malignant Disease

D. Hoelzer, U. Mahlknecht, D Hoelzer, 2000, Molecular medicine.